🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To validate the dosing algorithm for dabigatran etexilate in patients recei...
Status
Terminated
Location
1160.113.32003 Boehringer Ingelheim Investigational Site
Start Date
2011-10
Trial ID
NCT01452347
To assess safety, pharmacokinetics and the effect of dabigatran on coagulat...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02171455
Evaluation of potential ticagrelor effects on dabigatran exposure and evalu...
Status
Completed
Location
1160.141.1 Boehringer Ingelheim Investigational Site
Start Date
2012-05
Trial ID
NCT01595854
Treatments Being Tested
Study to investigate and compare safety, pharmacokinetics and pharmacodynam...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT02170909
Treatments Being Tested
To assess the extent of absorption of 12.5, 50 and 200 mg of BIBR 1048 MS w...
Status
Completed
Location
Multiple Locations
Start Date
2001-02
Trial ID
NCT02170792
Treatments Being Tested
To investigate the pharmacokinetic and pharmacodynamic interaction of dabig...
Status
Completed
Location
1160.142.1 Boehringer Ingelheim Investigational Site
Start Date
2012-11
Trial ID
NCT01734772
Treatments Being Tested
To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagul...
Status
Completed
Location
Multiple Locations
Start Date
1999-05
Trial ID
NCT02170831
To collect additional data relating to safety and indicators of efficacy fo...
Status
Terminated
Location
1160.138.32003 Boehringer Ingelheim Investigational Site
Start Date
2011-12
Trial ID
NCT01505881
The aim of this study is to investigate the effects of oral D-mannose table...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-01
Trial ID
NCT06360055
Treatments Being Tested
To assess the extend of absorption of 12.5, 25, 50 and 100 mg of BIBR 1048 ...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02170766
Treatments Being Tested